Medpage Today on MSN2d
Real-World Data on the RSV Vaccine for Older AdultsRegarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
A new study published today in JAMA Network Open shows that respiratory syncytial virus (RSV) was associated with a ...
Medpage Today on MSN17h
RSV Severity, Deaths on Par With Flu and COVIDIn addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...
RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...
In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of hospitalizations ...
Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...
Hosted on MSN2d
'Tripledemic' fear as RSV vaccine rolled outRSV is a common cause of coughs and colds but can also lead to severe respiratory illness, especially in the most vulnerable.
Glamour on MSN10d
RSV Symptoms: Here’s How the Virus Shows Up Differently in Babies, Adults, and SeniorsJust like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...
The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback